Index · Open funds
Growth venture funds investing in Biotech, New York
6 venture funds from 3 firms are raising or writing first checks for Growth-stage companies in Biotech, based in or investing in New York. Each fund qualifies by its stated focus or by deals it announced in the last 24 months.
6 funds
- BIOSPRING PARTNERS 2, LP$333K to $625K (estimated from fund size)Open, writing first checks
- Biospring Partners CHR, LP$167K to $313K (estimated from fund size)Open, writing first checks
- Biospring Partners Fund II, L.P.$11.67M to $21.88M (estimated from fund size)Open, writing first checks
- Arcventis Health Fund, L.P.$1.09M to $2.05M (estimated from fund size)Raising
Arcventis Health, NY
- Biospring Partners ABZ Fund V, L.P.$550K to $1.32M (estimated from fund size)Late investment period
- Signet Healthcare Partners QP Partnership V, LP$20M to $20M (stated by the fund)Late investment period